NCT01489813 2025-02-05
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
Emory University
Phase 2 Completed
Clinical Trials
12 trialsNCT02624388 2024-05-06
UVA-Gen001
University of Virginia
Phase 2 Terminated
NCT00244933 2023-06-22
Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT02766478 2022-09-27
GeniPro
Emory University
Phase 2 Terminated
NCT00376948 2021-03-01
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00882765 2020-07-31
Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Jonsson Comprehensive Cancer Center
Phase 2 Withdrawn
NCT02075112 2019-12-06
Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck
Emory University
Phase 1 Completed
NCT00769990 2017-12-13
Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases
Masonic Cancer Center, University of Minnesota
Phase 1/2 Withdrawn
NCT00099008 2013-05-21
Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT00058266 2012-07-19
Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy
Northwestern University
Phase 2 Terminated
NCT00005827 2012-04-24
Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 1 Withdrawn
NCT00546039 2008-09-30
Synthetic Genistein (BONISTEINâ„¢) in Patients Who Are Undergoing Surgery for Prostate Cancer
University Hospital, Aker
Phase 2 Unknown